List of Mochida Pharmaceutical patents

Patents where

Current Assignee

Name

‌

Mochida Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9452150 Jelly composition	Patent 9452150 was granted and assigned to Mochida Pharmaceutical on September, 2016 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	9452150	September 27, 2016
‌ US Patent 10399945 Tetrahydronaphthyl urea derivative	Patent 10399945 was granted and assigned to Mochida Pharmaceutical on September, 2019 by the United States Patent and Trademark Office.	‌ Mochida Pharmaceutical	‌ Mochida Pharmaceutical	United States Patent and Trademark Office	10399945	September 3, 2019
‌ US Patent 7264967 Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR binding	Patent 7264967 was granted and assigned to Mochida Pharmaceutical on September, 2007 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	7264967	September 4, 2007
‌ US Patent 7605226 Meltrins	Patent 7605226 was granted and assigned to Mochida Pharmaceutical on October, 2009 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	7605226	October 20, 2009
‌ US Patent 11325895 Crystals of tetrahydronaphthyl urea derivative		‌ Mochida Pharmaceutical	‌ Mochida Pharmaceutical	United States Patent and Trademark Office	11325895	May 10, 2022
‌ US Patent 8389692 Anti-platelet membrane glycoprotein VI monoclonal antibody	Patent 8389692 was granted and assigned to Mochida Pharmaceutical on March, 2013 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	8389692	March 5, 2013
‌ US Patent 7498359 Composition and method for preventing recurrence of stroke	Patent 7498359 was granted and assigned to Mochida Pharmaceutical on March, 2009 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	7498359	March 3, 2009
‌ US Patent 7977461 Anti-platelet membrane glycoprotein VI monoclonal antibody	Patent 7977461 was granted and assigned to Mochida Pharmaceutical on July, 2011 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	7977461	July 12, 2011
‌ US Patent 7608684 Soluble CD14 antigen	Patent 7608684 was granted and assigned to Mochida Pharmaceutical on October, 2009 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	7608684	October 27, 2009
‌ US Patent 9889108 Compositions and methods for treating non-alcoholic steatohepatitis	Patent 9889108 was granted and assigned to Mochida Pharmaceutical on February, 2018 by the United States Patent and Trademark Office.	‌ Mochida Pharmaceutical	‌ Mochida Pharmaceutical	United States Patent and Trademark Office	9889108	February 13, 2018
‌ US Patent 9006285 Therapeutic agent for hepatitis C	Patent 9006285 was granted and assigned to Mochida Pharmaceutical on April, 2015 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	9006285	April 14, 2015
‌ US Patent 9060981 Marker associated with non-alcoholic steatohepatitis	Patent 9060981 was granted and assigned to Mochida Pharmaceutical on June, 2015 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	9060981	June 23, 2015
‌ US Patent 9700537 Composition for preventing the occurrence of cardiovascular event in multiple risk patient	Patent 9700537 was granted and assigned to Mochida Pharmaceutical on July, 2017 by the United States Patent and Trademark Office.	‌ Mochida Pharmaceutical	‌ Mochida Pharmaceutical	United States Patent and Trademark Office	9700537	July 11, 2017
‌ US Patent 6858599 Tricyclic compound having spiro union	Patent 6858599 was granted and assigned to Mochida Pharmaceutical on February, 2005 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	6858599	February 22, 2005
‌ US Patent 8461141 Preventive or therapeutic drug for Alzheimer-type dementia	Patent 8461141 was granted and assigned to Mochida Pharmaceutical on June, 2013 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	8461141	June 11, 2013
‌ US Patent 8252905 Anti-CD14 antibody fusion protein	Patent 8252905 was granted and assigned to Mochida Pharmaceutical on August, 2012 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	8252905	August 28, 2012
‌ US Patent 8367725 Composition and/or method for preventing onset and/or recurrence of cardiovascular events	Patent 8367725 was granted and assigned to Mochida Pharmaceutical on February, 2013 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	8367725	February 5, 2013
‌ US Patent 10927079 Intermediate compound of novel tetrahydronaphthyl urea derivative	Patent 10927079 was granted and assigned to Mochida Pharmaceutical on February, 2021 by the United States Patent and Trademark Office.	‌ Mochida Pharmaceutical	‌ Mochida Pharmaceutical	United States Patent and Trademark Office	10927079	February 23, 2021
‌ US Patent 7494987 Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient	Patent 7494987 was granted and assigned to Mochida Pharmaceutical on February, 2009 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	7494987	February 24, 2009
‌ US Patent 6905684 Preventives and remedies for diffuse lung diseases	Patent 6905684 was granted and assigned to Mochida Pharmaceutical on June, 2005 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	6905684	June 14, 2005
‌ US Patent 7910751 Heterocyclidene acetamide derivative	Patent 7910751 was granted and assigned to Mochida Pharmaceutical on March, 2011 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	7910751	March 22, 2011
‌ US Patent 8802718 Composition for preventing the occurrence of cardiovascular event in multiple risk patient	Patent 8802718 was granted and assigned to Mochida Pharmaceutical on August, 2014 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	8802718	August 12, 2014
‌ US Patent 8383839 Heterocyclidene acetamide derivative	Patent 8383839 was granted and assigned to Mochida Pharmaceutical on February, 2013 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	8383839	February 26, 2013
‌ US Patent 8476287 3-hydroxy-5-arylisothiazole derivative	Patent 8476287 was granted and assigned to Mochida Pharmaceutical on July, 2013 by the United States Patent and Trademark Office.		‌ Mochida Pharmaceutical	United States Patent and Trademark Office	8476287	July 2, 2013
‌ US Patent 9486433 Compositions and methods for treating non-alcoholic steatohepatitis	Patent 9486433 was granted and assigned to Mochida Pharmaceutical on November, 2016 by the United States Patent and Trademark Office.	‌ Mochida Pharmaceutical	‌ Mochida Pharmaceutical	United States Patent and Trademark Office	9486433	November 8, 2016

Results per page:

93 results

0 selected

93 results

0 selected